Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
Jack W. Hsu(University of Florida Health), John R. Wingard(University of Florida Health), Siddhartha Ganguly(University of Kansas Medical Center), Christopher Bredeson, Jennifer A. Sees(National Marrow Donor Program), Nosha Farhadfar(University of Florida Health), Galen E. Switzer(University of Pittsburgh), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Hemant S. Murthy(University of Florida), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Saurabh Chhabra(Medical College of Wisconsin), Nirali N. Shah(National Institutes of Health), Ibrahim Ahmed(Children's Mercy Hospital), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Thomas R. Spitzer(Harvard University), Raquel M. Schears(Mayo Clinic in Arizona), Peiman Hematti(UW Health University Hospital), Dennis L. Confer(National Marrow Donor Program), Sachiko Seo(National Cancer Center Hospital East), Muneer H. Abidi(Spectrum Health), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Usama Gergis(Thomas Jefferson University Hospital), Richard F. Olsson(AstraZeneca (Netherlands)), Jane L. Liesveld(Strong Memorial Hospital), Amir Steinberg(New York Medical College), Bipin N. Savani(Vanderbilt University Medical Center), Michele W. Sugrue(University of Florida), Melhern Solh(Northside Hospital), Soyoung Kim(Medical College of Wisconsin), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Rammurti T. Kamble(Baylor College of Medicine), Phyllis Warkentin(University of Iowa), Paulo N. Anderlini(The University of Texas MD Anderson Cancer Center), Gregory A. Hale(Johns Hopkins University), Hillard M. Lazarus(University Hospitals of Cleveland), Michael A. Pulsipher(Primary Children's Hospital)
Cited by 10
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k